1140
S. M. S. Ló et al. / Tetrahedron Letters 54 (2013) 1137–1140
17. (a) Lee, C.-H.; Lindsey, J. S. Tetrahedron 1994, 50, 11427; (b) Littler, B. J.; Miller,
M. A.; Hung, C. H.; Wagner, R. W.; O’Shea, D. F.; Boyle, P. D.; Lindsey, J. S. J. Org.
Chem. 1999, 64, 1391–1396.
moiety attached to the dipyrryl unit through a carbon–carbon
bond. This approach allows the use of diverse carbohydrates as
starting materials. Dipyrranes 12–16 are currently being employed
for the synthesis of C-1-deoxyalditol- and C-glycoside-meso-
substituted-porphyrins in our laboratories.
18. To
a cooled (0 °C), stirred mixture of peracetylated diethyl dithioacetal
(1 mmol), THF (2 mL), and Et2O (5 mL), a solution of H5IO6 (2 mmol) in THF
(1 mL) was added drop wise. The resulting mixture was warmed to room
temperature, stirred for 20 min (60 min for 9), diluted with 0.1 M phosphate
buffer, and then extracted with CHCl3. The organic phase containing the freshly
prepared aldehyde was washed with 10% aqueous Na2SO3 solution, dried
(Na2SO4), and concentrated. Pyrrole (25 mmol) and TFA (0.1 mmol) were then
added to the concentrated extract and the resulting mixture was stirred for
30 min under Argon (see details in Supplementary data). Reaction mixture was
then quenched with 0.1 M NaOH and extracted with chloroform. The organic
phase was washed with water, dried over Na2SO4, concentrated under vacuum,
and purified by flash chromatography with ethyl acetate/hexanes as mobile
phase (5:7 for compounds 12–14, 2:1 for 15 and 1:1 for 16).
Acknowledgments
The authors are thankful to Fundação Araucária (15152) and
PRONEX-Carboidratos (14669) for financial support. S.M.S.L.
and A.O. thank the scholarships from REUNI program. M.E.R.D.
and M.D.N. are Research Members of the National Research Council
of Brazil (CNPq). The authors are indebted to Professor Marcelo
Muller dos Santos, M.Sc. Samuel Habib and Dr. Peter Goekjian for
high resolution ESI mass experiments.
Compound 12: ½a 2D2
ꢁ
+12.0 (c 0.5 , CHCl3); 1H NMR (400 MHz, CDCl3) d = 8.52 (b,
1H, NH), 8.26 (b, 1H, NH0), 6.71 (b, 1H, H-1 pyrrole), 6.68 (b, 1H, H-10 pyrrole),
6.13 (b, 1H, H-2 pyrrole), 6.12 (b, 1H, H-20 pyrrole), 6.05 (b, 1H, H-3 pyrrole),
6.02 (b, 1H, H-30 pyrrole), 5.49–5.40 (m, 2H, H-2, H-3), 5.27 (dd, J = 9.5, 1.0 Hz,
1H, H-4), 5.24–5.18 (m, 1H, H-5), 4.32 (d, J = 6.6 Hz, 1H, H-1), 4.27 (dd, J = 11.8,
4.7 Hz, 1H, H-6a), 3.79 (dd, J = 11.8, 7.5 Hz, 1H, H-6b), 2.09, 2.01, 2.01, 2.00,
1.91 (5s, 15H, COCH3). 13C NMR (101 MHz, CDCl3) d = 171.1, 170.6, 170.4,
170.0, 169.9 (5C, C@O), 128.7 (1C, C-4 pyrrole), 127.4 (1C, C-40 pyrrole), 117.9
(1C, C-1 pyrrole), 117.6 (1C, C-10 pyrrole),108.8 (1C, C-2, pyrrole), 108.6 (1C, C-
3 pyrrole), 108.4 (2C, C-20 pyrrole), 106.8 (1C, C-30 pyrrole), 71.7 (1C, C-2), 68.9
(1C, C-3), 68.3 (1C, C-4), 67.9 (1C, C-5), 62.4 (1C, C-6), 39.8 (1C, C-1), 20.9, 20.8,
20.8, 20.7, 20.7 (5C, COCH3). HRMS (ESI): m/z calcd for C24H30N2O10Na+:
529.1793; found: 529.1779.
Supplementary data
Supplementary data associated with this article can be found, in
Compound 13: ½a 2D2
ꢁ
ꢀ15.9 (c 1.0 , DMSO); 1H NMR (400 MHz, DMSO) d = 10.49
References and notes
(b, 1H, NH), 10.39 (b, 1H, NH0), 6.62 (d, J = 1.6 Hz, 1H, H-1 pyrrole), 6.58 (d,
J = 1.6 Hz, 1H, H-10 pyrrole), 5.95–5.86 (m, 4H, H-2, H-20, H-3, H-30 pyrrole),
5.43 (dd, J = 7.3, 5.2 Hz, 1H, H-2), 5.20 (dd, J = 6.2, 4.8 Hz, 1H, H-4), 5.00–4.91
(m, 2H, H-3, H-5), 4.27 (d, J = 7.4 Hz, 1H, H-1), 4.10 (dd, J = 12.2, 3.1 Hz, 1H, H-
6a), 4.06–3.99 (m, 1H, H-6b), 2.05 2.00, 1.99, 1.89, 1.88 (5s, 15H, COCH3). 13C
NMR (101 MHz, DMSO) d = 170.0, 169.6, 169.3, 169.1, 169.0 (5C, C@O), 128.7
(1C, C-4 pyrrole), 128.4 (1C, C-40 pyrrole), 117.2 (1C, C-1 pyrrole), 117.0 (1C, C-
10 pyrrole), 107.3, 106.9, 106.6, 105.6 (4C, C-2, C-3, C-20, C-30 pyrrole), 72.3 (1C,
C-2), 69.2 (1C, C-3), 68.7 (1C, C-4), 68.6 (1C, C-5), 60.9 (1C, C-6), 38.9 (1C, C-1),
20.4–20.3 (5C, COCH3). HRMS (ESI): m/z calcd for C24H30N2O10Na+: 529.1793;
found: 529.1768.
1. Zheng, X.; Pandey, R. K. Anti-Cancer Agents Med. Chem. 2008, 8, 241–268.
2.
A recent review proposes the use of the term ‘dipyrrane’ instead of
‘dipyrromethane’: Gryko, D. T.; Gryko, D.; Lee, C.-H. Chem. Soc. Rev. 2012, 41,
3780–3789.
3. Casiraghi, G.; Cornia, M.; Zanardi, F.; Rassu, G.; Ragg, E.; Bortolini, R. J. Org.
Chem. 1994, 59, 1801–1808.
4. Cornia, M.; Capacchi, S.; Del Pogetto, M.; Pelosi, G.; Fava, G. G. Tetrahedron:
Asymmetry 1997, 8, 2905–2912.
ˇ
5. Štepánk, P.; Dukh, M.; Šaman, D.; Moravcová, J.; Kniezo, L.; Monti, D.; Venanzi,
M.; Mancini, G.; Drašar, P. Org. Biomol. Chem. 2007, 5, 960–970.
6. (a) Leffler, H.; Barondes, S. H. J. Biol. Chem. 1986, 261, 10119–10126; (b) Hadari,
R. H.; Arbel-Goren, R.; Levy, Y.; Amsterdan, A.; Alon, R.; Zakut, R.; Zick, Y. J. Cell.
Sci. 2000, 113, 2385–2397.
7. (a) Gonçalves, A. G.; Noseda, M. D.; Duarte, M. E. R.; Grindley, T. B. Carbohydr.
Res. 2006, 341, 1753–1757; (b) Gonçalves, A. G.; Noseda, M. D.; Duarte, M. E. R.;
Grindley, T. B. J. Org. Chem. 2007, 72, 9896–9904.
8. Ducatti, D. R. B.; Massi, A.; Noseda, M. D.; Duarte, M. E. R.; Dondoni, A. Org.
Biomol. Chem. 2009, 7, 576–588.
9. Ducatti, D. R. B.; Massi, A.; Noseda, M. D.; Duarte, M. E. R.; Dondoni, A. Org.
Biomol. Chem. 2009, 7, 1980–1986.
Compound 14: ½a 2D2
ꢁ
+19.5 (c 1.0 , DMSO); 1H NMR (400 MHz, DMSO) d = 10.64
(b, 1H, NH pyrrole), 10.34 (b, 1H, NH0 pyrrole), 6.63 (b, 1H, H-1 pyrrole), 6.55 (d,
J = 1.2 Hz, 1H, H-10 pyrrole), 5.98–5.88 (m, 2H, H-2, H-3 pyrrole), 5.88–5.79 (m,
2H, H-20, H-30 pyrrole), 5.56 (dd, J = 8.7, 5.7 Hz, 1H, H-2), 5.42 (d, J = 8.4 Hz, 1H,
H-4), 4.95–4.84 (m, 2H, H-3, H-5), 4.34 (d, J = 8.8 Hz, 1H, H-1), 4.08 (dd, J = 12.4,
2.6 Hz, 1H, H-6a), 4.04–3.97 (m, 1H, H-6b), 2.07, 1.99, 1.89, 1.82, 1.82 (5s, 15H,
COCH3). 13C NMR (101 MHz, DMSO) d = 170.0, 169.5, 169.2, 169.2, 169.2 (5C,
C@O), 129.1 (1C, C-4 pyrrole), 128.5 (1C, C-40 pyrrole), 117.4 (1C, C-1 pyrrole),
116.9 (1C, C-10 pyrrole), 107.2 (1C, C-2 pyrrole), 106.9 (1C, C-20 pyrrole), 106.0
(1C, C-3 pyrrole), 105.8 (1C, C-30 pyrrole), 72.0 (1C, C-2), 68.8 (1C, C-3), 67.7
(1C, C-5), 66.6 (1C, C-4), 61.3 (1C, C-6), 38.9 (1C, C-1), 20.7, 20.5, 20.4, 20.4, 20.4
(COCH3). HRMS (ESI): m/z calcd for C24H30N2O10Na+: 529.1793; found:
529.1773.
10. Wolfrom, M. L. J. Am. Chem. Soc. 1930, 52, 2464–2473.
11. Roberts, J. C.; Nagasawa, H. T.; Zera, R. T.; Fricke, R. F.; Goon, D. J. W. J. Med.
Chem. 1987, 30, 1891–1896.
Compound 15: ½a 2D2
ꢁ
ꢀ6.51 (c 0.3 , DMSO); 1H NMR (400 MHz, DMSO) d = 10.31
12. Mercaptolysis–acetylation one-pot procedure: sugar starting material 1–4 (or
agarose 5 hydrolyzate) was dissolved to a concentration of 40 g% in a mixture
of conc HCl (37%)/EtSH (3:2, v/v) at 0 °C. Mercaptolysis was kept at 0 °C for
different reaction times, accordingly to the starting material (see Table 1). The
resulting mixture was then directly added of 22 volumes (in relation to HCl/
EtSH volume) of pyridine/acetic anhydride (6:5, v/v). Reaction was stirred at
0 °C for an hour and then kept at room temperature for 18 h. Ice water was
added to the reaction mixture and the product was extracted with CHCl3. The
organic phase was washed with 5% aqueous CuSO4 solution and then water,
dried over Na2SO4 and concentrated. The residue was purified by flash column
chromatography on silica gel using ethyl acetate/hexanes as mobile phase (1:3
for compounds 6–8, 2:3 for 9 and 1:1 for 10).
(b, 1H, NH), 10.27 (b, 1H, NH0), 6.62 (b, 1H, H-1 pyrrole), 6.55 (b, 1H, H-10
pyrrole), 5.97–5.85 (m, 4H, H-2, H-3, H-20, H-30 pyrrole), 5.56 (t, J = 6.0 Hz, 1H,
H-2), 5.24 (d, J = 3.5 Hz, 1H, H-40), 5.18 (dd, J = 9.5, 3.5 Hz, 1H, H-30), 5.01–4.95
(m, 1H, H-5), 4.93–4.82 (m, 3H, H-3, H-10, H-20), 4.40 (d, J = 6.8 Hz, 1H, H-1),
4.25 (t, J = 6.5 Hz, 1H, H-50), 4.14 (dd, J = 12.0, 2.5 Hz, 1H, H-6a0), 4.08 (t,
J = 4.8 Hz, 1H, H-4), 4.05–3.89 (m, 3H, H-6a, H-6b, H-6b0), 2.13, 2.00, 1.98, 1.97,
1.97, 1.97, 1.91, 1.89 (8s, 24H, COCH3). 13C NMR (101 MHz, DMSO) d = 170.0,
169.9, 169.8, 169.5, 169.4, 169.1, 169.1, 168.8 (8C, C@O), 129.0 (1C, C-4
pyrrole), 128.4 (1C, C-40 pyrrole), 117.2 (1C, C-1 pyrrole), 116.8 (1C, C-10
pyrrole), 107.2, 106.9, 106.8 (3C, C-2, C-20, C-3 pyrrole), 105.2 (1C, C-30 pyrrole),
99.8 (1C, C-10), 75.8 (1C, C-4), 72.4 (1C, C-2), 70.4 (1C, C-30), 70.1, 69.9 (2C, C-5,
C-50), 69.9 (1C, C-3), 69.0 (1C, C-20), 67.2 (1C, C-40), 61.1 (2C, C-6, C-60), 38.3 (1C,
C-1), 20.5, 20.5, 20.4, 20.4, 20.3, 20.3, 20.3, 20.3 (8C, COCH3). HRMS (ESI): m/z
calcd for C36H46N2O18Na+: 817.2638; found: 817.2648.
13. Khan, A. T.; Khan, M. M. Carbohydr. Res. 2010, 335, 21392145.
14. Compound 9: ½a D22
ꢁ
+29.7 (c 1.0, DMSO); 1H NMR (400 MHz, CDCl3) d = 5.76 (dd,
J = 5.7, 4.5 Hz, 1H, H-3), 5.48 (t, J = 5.3 Hz, 1H, H-2), 5.39 (d, J = 3.4 Hz, 1H, H-40),
5.24–5.17 (m, 1H, H-5), 5.14 (dd, J = 10.3, 7.9 Hz, 1H, H-20), 5.02 (dd, J = 10.5,
3.5 Hz, 1H, H-30), 4.75 (d, 1H, J = 7.8 Hz, H-10), 4.47 (dd, J = 12.4, 2.8 Hz, 1H, H-
6a), 4.25 (t, J = 4.6 Hz, 1H, H-4), 4.21–4.09 (m, 4H, H-1, H-6b, H-6a0, H-6b0), 3.92
(t, J = 6.8 Hz, 1H, H-50), 2.79–2.62 (m, 4H, CH2CH3), 2.15, 2.10, 2.09, 2.07, 2.07,
2.06, 2.06, 1.98 (8s, 24H, COCH3), 1.26 (dd, J = 14.1, 7.2 Hz, 6H, CH2CH3). 13C
NMR (101 MHz, CDCl3) d = 170.5, 170.4, 170.1, 170.1, 169.8, 169.7, 169.7, 169.2
(8C, C@O), 100.5 (1C, C-10), 75.4 (1C, C-4), 72.4 (1C, C-2), 71.2 (2C, C-3, C-50),
71.0 (2C, C-5, C-30), 69.1 (1C, C-20), 67.0 (1C, C-40), 62.1 (1C, C-6), 61.4 (1C, C-60),
51.3 (1C, C-1), 25.5, 24.8 (2C, CH2CH3), 20.8 (8C, COCH3), 14.4 (2C, CH2CH3).
HRMS (ESI): m/z calcd for C32H48O18S2Na+: 807.2174; found: 807.2183.
15. Shi, X.-X.; Khanapure, S. P.; Rokach, J. Tetrahedron Lett. 1996, 37, 4331–4334.
16. (a) Wolfrom, M. L.; Konigsberg, M.; Weisblat, D. I. J. Am. Chem. Soc. 1939, 61,
Compound 16: ½a 2D2
ꢁ
+16.4 (c 1.0 , DMSO); 1H NMR (400 MHz, CDCl3) d = 8.47 (b,
1H, NH), 8.44 (b, 1H, NH0), 6.64 (b, 2H, H-1, H-10 pyrrole), 6.13–6.02 (m, 4H, H-
2, H-3, H-20, H-30 pyrrole), 5.67 (dd, J = 8.5, 3.7 Hz, 1H, H-2), 5.39 (d, J = 3.1 Hz,
1H, H-40), 5.13 (dd, J = 10.4, 7.9 Hz, 1H, H-20), 5.00 (dd, J = 10.4, 3.4 Hz, 1H, H-
30), 4.94 (d, J = 4.2 Hz, 1H, H-4), 4.60 (d, J = 7.9 Hz, 1H, H-10), 4.53 (d, J = 8.5 Hz,
1H, H-1), 4.20 (dd, J = 11.4, 6.0 Hz, 1H, H-6a0), 4.13 (dd, J = 11.7, 6.7 Hz, 1H, H-
6b0), 3.98–3.91 (m, 3H, H-5, H-6a, H-50), 3.91–3.84 (m, 2H, H-3, H-6b), 2.14,
2.06, 2.03, 1.96, 1.96, 1.91 (6s, 18H, COCH3). 13C NMR (101 MHz, CDCl3)
d = 170.9, 170.6, 170.3, 170.2, 170.0, 169.6 (6C, C@O), 128.9 (1C, C-4 pyrrole),
128.6 (1C, C-40 pyrrole), 117.4 (2C, C-1, C-10 pyrrole), 108.7 (1C, C-2 pyrrole),
108.3 (1C, C-20 pyrrole), 107.4 (1C, C-3 pyrrole), 106.7 (1C, C-30 pyrrole), 101.6
(1C, C-10), 85.6 (1C, C-5), 83.6 (1C, C-3), 79.7 (1C, C-4), 73.3 (1C, C-2), 71.1 (1C,
C-50), 71.1 (1C, C-6), 70.8 (1C, C-30), 68.8 (1C, C-20), 67.3 (1C, C-40), 61.5 (1C, C-
60), 39.5 (1C, C-1), 21.0, 20.9, 20.6, 20.6, 20.6, 20.6 (6C, COCH3). HRMS (ESI): m/z
calcd for C32H40N2O15Na+: 715.2321; found: 715.2300.
´
574–576; (b) Miljkovic, M.; Dropkin, D.; Hagel, P.; Habash-Marino, M.
Carbohydr. Res. 1984, 128, 11–20.